Literature DB >> 19523438

RNA interference: emerging diagnostics and therapeutics tool.

K Shrey1, A Suchit, M Nishant, R Vibha.   

Abstract

RNA interference has been recognized to be an efficient mechanism for the sequence specific inhibition of gene-expression caused by 21-23bp long dsRNA. This is a potent tool to study gene function and is ready to lend a hand in the treatment of disease. Two main classes of dsRNA involved are short-interfering RNA and micro RNA which differ in biogenesis and modes of target regulation. The discovery of RNAi has led to the development in the field of biomedical research. The evolution of RNAi has led to diverse applications such as identification of gene function, identification of disease causing genes and therapeutics. This homology dependent gene silencing, hence has a great latent in transcriptional regulation and medicine. This review summarizes the role of RNAi in human health and diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523438     DOI: 10.1016/j.bbrc.2009.06.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.

Authors:  Hyun-Jong Cho; Saeho Chong; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
Journal:  Pharm Res       Date:  2011-12-15       Impact factor: 4.200

Review 2.  The dicey role of Dicer: implications for RNAi therapy.

Authors:  William M Merritt; Menashe Bar-Eli; Anil K Sood
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes.

Authors:  Chun-Mei Zhang; Xue-Qi Zeng; Rong Zhang; Chen-Bo Ji; Mei-Ling Tong; Xia Chi; Xi-Ling Li; Jia-Zheng Dai; Min Zhang; Yan Cui; Xi-Rong Guo
Journal:  J Bioenerg Biomembr       Date:  2010-11-16       Impact factor: 2.945

4.  Therapeutic potential of a combination of two gene-specific small interfering RNAs against clinical strains of Acanthamoeba.

Authors:  Jacob Lorenzo-Morales; Carmen M Martín-Navarro; Atteneri López-Arencibia; María A Santana-Morales; Raquel N Afonso-Lehmann; Sutherland K Maciver; Basilio Valladares; Enrique Martínez-Carretero
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

Review 5.  The regulatory function of piRNA/PIWI complex in cancer and other human diseases: The role of DNA methylation.

Authors:  Dong-Dong Jia; Hui Jiang; Yi-Fei Zhang; Yu Zhang; Li-Li Qian; Yin-Feng Zhang
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

6.  siRNA-mediated downregulation of GluN2B in the rostral anterior cingulate cortex attenuates mechanical allodynia and thermal hyperalgesia in a rat model of pain associated with bone cancer.

Authors:  Yongguang Xu; Gongming Wang; Xuli Zou; Zaiqi Yang; Qin Wang; Hao Feng; Mengyuan Zhang
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

7.  Modeling RNA interference in mammalian cells.

Authors:  Giulia Cuccato; Athanasios Polynikis; Velia Siciliano; Mafalda Graziano; Mario di Bernardo; Diego di Bernardo
Journal:  BMC Syst Biol       Date:  2011-01-27

8.  High AU content: a signature of upregulated miRNA in cardiac diseases.

Authors:  Richa Gupta; Neha Soni; Purbasa Patnaik; Ishita Sood; Rahul Singh; Kamal Rawal; Vibha Rani
Journal:  Bioinformation       Date:  2010-09-20

9.  PfSMAD4 plays a role in biomineralization and can transduce bone morphogenetic protein-2 signals in the pearl oyster Pinctada fucata.

Authors:  Mi Zhao; Yu Shi; Maoxian He; Xiande Huang; Qi Wang
Journal:  BMC Dev Biol       Date:  2016-04-26       Impact factor: 1.978

10.  Multi-targeted gene silencing strategies inhibit replication of Canine morbillivirus.

Authors:  Otávio Valério de Carvalho; Marcus Rebouças Santos; Juliana Lopes Rangel Fietto; Mauro Pires Moraes; Márcia Rogéria de Almeida; Gustavo Costa Bressan; Lindomar José Pena; Abelardo Silva-Júnior
Journal:  BMC Vet Res       Date:  2020-11-19       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.